XML 12 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
BALANCE SHEETS - USD ($)
Dec. 31, 2017
Sep. 30, 2017
CURRENT ASSETS:    
Cash and cash equivalents $ 2,142,734 $ 2,369,438
Receivables 47,610 218,481
Prepaid expenses 805,729 826,429
Deposits - current portion 0 150,000
Inventory used for R&D and manufacturing 644,749 672,522
Total current assets 3,640,822 4,236,870
Plant, property and equipment, net 16,647,211 16,793,220
Patent costs, net 214,872 223,167
Deposits 1,670,917 1,670,917
Total Assets 22,173,822 22,924,174
CURRENT LIABILITIES:    
Accounts payable 7,872,799 8,196,334
Accrued expenses 970,042 936,698
Due to employees 846,751 693,831
Notes payable 874,593 994,258
Derivative instruments, current portion 19,724 10,984
Other current liabilities 11,815 12,449
Total current liabilities 10,595,724 10,844,554
Derivative instruments - net of current portion 2,991,908 2,042,418
Lease Liability 13,255,468 13,211,925
Deferred revenue 126,550 125,000
Other liabilities 38,212 37,254
Total liabilities 27,007,862 26,261,151
STOCKHOLDERS' DEFICIT    
Preferred stock, $.01 par value-200,000 shares authorized; -0- shares issued and outstanding 0 0
Common stock, $.01 par value - 600,000,000 shares authorized; 13,258,051 and 11,903,133 shares issued and outstanding at December 31, 2017 and September 30, 2017, respectively 132,581 119,031
Additional paid-in capital 300,975,618 296,298,401
Accumulated deficit (305,942,239) (299,754,409)
Total stockholders' deficit (4,834,040) (3,336,977)
TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT $ 22,173,822 $ 22,924,174